We agree that distinct staining of M1 and M2 markers in RCC tissue with increased sample number and the use of patient-derived M2 macrophages from RCC patients will clarify the role of the CCL20-CCR6 axis on RCC progression. The gene discussed is CCR6; the disease is renal cell carcinoma.